Immunologix's Incubator/Accelerator Round

Immunologix raised a round of funding on December 21, 2009. Investors include SCRA MUSC Innovation Center.

Immunologix is a human antibody development company founded on a proprietary technology that transforms naive B-cells into fully human monoclonal antibodies targeting any antigen. In October 2011, Im…

Articles about Immunologix's Incubator/Accelerator Round: